Presidio Medical raises $72M for ultra-low frequency neuromod

Presidio Medical closed a $72 million Series C funding round to support its ultra-low frequency (ULF) neuromodulation platform.

Related Keywords

David Neustaedter ,Michael Onuscheck , ,Presidio Medical ,Invus Opportunities ,Action Potential Venture ,Shangbay Capital ,San Francisco Based Presidio ,